A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells

Efficient homing/mobilization of human hematopoietic stem/progenitor cells to/from bone marrow niches enhances their therapeutic efficacy. Additionally, homing is dependent on cell source and may be modulated by prior ex vivo cell expansion. Here, we describe a novel application of a 3-dimensional t...

Full description

Bibliographic Details
Main Authors: Pepperell, E, Watt, S
Format: Journal article
Language:English
Published: Elsevier 2013
_version_ 1797056284561768448
author Pepperell, E
Watt, S
author_facet Pepperell, E
Watt, S
author_sort Pepperell, E
collection OXFORD
description Efficient homing/mobilization of human hematopoietic stem/progenitor cells to/from bone marrow niches enhances their therapeutic efficacy. Additionally, homing is dependent on cell source and may be modulated by prior ex vivo cell expansion. Here, we describe a novel application of a 3-dimensional time-lapse method for assessing trafficking of individual human cord blood CD133(+) hematopoietic stem/progenitor cells in vitro, using the key chemokine CXCL12 as a paradigm. This new methodology allows distinction between chemotactic responses (displacement of center of mass and the forward migration index of the cells), and chemokinetic responses such as total cell path traveled in any direction (accumulated distance) and cell velocity in a 3-dimensional matrix. Other key advantages of this novel assay over existing assays include the ability to assess individual cell migration over times comparable to in vivo homing and rapid mobilization assays (18-24h) and to directly compare the strength or response of individual hematopoietic progenitor cells to different or competing stimuli and small molecule inhibitors in a single assay prior to analyses in vivo. Importantly, using this method, our results demonstrate definitively that CXCL12 regulates the chemotactic responses of human cord blood CD133(+) cells, but not their random migration or chemokinesis.
first_indexed 2024-03-06T19:21:13Z
format Journal article
id oxford-uuid:1a2773d1-8097-40c3-aec0-1a98b088c96b
institution University of Oxford
language English
last_indexed 2024-03-06T19:21:13Z
publishDate 2013
publisher Elsevier
record_format dspace
spelling oxford-uuid:1a2773d1-8097-40c3-aec0-1a98b088c96b2022-03-26T10:53:09ZA novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cellsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1a2773d1-8097-40c3-aec0-1a98b088c96bEnglishSymplectic Elements at OxfordElsevier2013Pepperell, EWatt, SEfficient homing/mobilization of human hematopoietic stem/progenitor cells to/from bone marrow niches enhances their therapeutic efficacy. Additionally, homing is dependent on cell source and may be modulated by prior ex vivo cell expansion. Here, we describe a novel application of a 3-dimensional time-lapse method for assessing trafficking of individual human cord blood CD133(+) hematopoietic stem/progenitor cells in vitro, using the key chemokine CXCL12 as a paradigm. This new methodology allows distinction between chemotactic responses (displacement of center of mass and the forward migration index of the cells), and chemokinetic responses such as total cell path traveled in any direction (accumulated distance) and cell velocity in a 3-dimensional matrix. Other key advantages of this novel assay over existing assays include the ability to assess individual cell migration over times comparable to in vivo homing and rapid mobilization assays (18-24h) and to directly compare the strength or response of individual hematopoietic progenitor cells to different or competing stimuli and small molecule inhibitors in a single assay prior to analyses in vivo. Importantly, using this method, our results demonstrate definitively that CXCL12 regulates the chemotactic responses of human cord blood CD133(+) cells, but not their random migration or chemokinesis.
spellingShingle Pepperell, E
Watt, S
A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells
title A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells
title_full A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells
title_fullStr A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells
title_full_unstemmed A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells
title_short A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells
title_sort novel application for a 3 dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic cd133 stem progenitor cells
work_keys_str_mv AT pepperelle anovelapplicationfora3dimensionaltimelapseassaythatdistinguisheschemotacticfromchemokineticresponsesofhematopoieticcd133stemprogenitorcells
AT watts anovelapplicationfora3dimensionaltimelapseassaythatdistinguisheschemotacticfromchemokineticresponsesofhematopoieticcd133stemprogenitorcells
AT pepperelle novelapplicationfora3dimensionaltimelapseassaythatdistinguisheschemotacticfromchemokineticresponsesofhematopoieticcd133stemprogenitorcells
AT watts novelapplicationfora3dimensionaltimelapseassaythatdistinguisheschemotacticfromchemokineticresponsesofhematopoieticcd133stemprogenitorcells